
Empowering investors with insights, analysis and expert recommendations to navigate financial markets with confidence.
Open a Free Basic Account Now to Start Receiving Timely High-Conviction Investment Ideas and Actionable Trade Signals Designed To Help You Stay Ahead, and also See Our Complete History of Past Investment and Trading Results.
.webp&w=2048&q=75)
Trading Halts and Suspensions Explained: What They Are and How They Affect Investors
Oct 3, 2026 | Proactive Equities Team
.webp&w=2048&q=75)
Hazer Group (ASX: HZR): Licensing Wins Pile Up as Shares Sit at a Key Support Level
Oct 2, 2026 | Proactive Equities Team

OFX Group (ASX: OFX): Cyber Scare Puts $1 Equals Takeover under the Microscope
Oct 2, 2026 | Proactive Equities Team

Transurban Group (ASX: TCL): $4.5b Sydney Toll Road Deal Locks in Control without New Equity
Oct 2, 2026 | Proactive Equities Team

Ampol (ASX: ALD): $225m Evie Deal Plugs Fuel Giant into Australia's Electric Future
Oct 2, 2026 | Proactive Equities Team

Caprice Resources (ASX: CRS): Valuing the Gold Before It Becomes a Resource
Oct 2, 2026 | Proactive Equities Team
.webp&w=828&q=75)
Hazer Group (ASX: HZR) is pushing its capital-light hydrogen and graphite licensing model toward commercial execution, with a FortisBC facility underway and a new Japanese utility study won.

OFX Group (ASX: OFX) is probing a cyber incident involving unauthorised data access while its $1 Equals takeover awaits financing, and Funds SA has dropped below the 5% substantial holder threshold.

Caprice Resources (ASX: CRS) is an exploration-stage gold company focused on Western Australia’s Murchison Goldfields. Its Island Gold Project is advancing toward a maiden MRE, supported by high-grade drilling, while valuation remains highly dependent on exploration success and future resource definition.
.webp&w=828&q=75)
Emyria (ASX: EMD) has opened its first Sydney Empax clinic, expanding its treatment network to four Australian states. The new facility adds treatment capacity, while patient volumes and reimbursement arrangements remain key factors in its commercial development.

Dateline Resources (ASX: DTR) has gained US Department of War backing in its bid to restart Colosseum, a gold and rare earths project in California, as a key court hearing nears.

Critica (ASX: CRI) released a Mt Lindsay Scoping Study showing a $1 billion NPV underground tin-tungsten operation, though shares eased on the day. With funding pathways still being explored, the company continues advancing its Jupiter rare earths project in parallel.

Excite Technology Services (ASX: EXT) has locked in a $3.2 million, 24-month extension with a federal agency, its first big win since restructuring, as the cybersecurity small-cap works to prove its turnaround.

Racura Oncology's CEO-owned Nucleics added 23,000 shares near a 52-week low, while new data backs the company's MYC-silencing cancer drug ahead of a November Singapore conference.
.webp&w=828&q=75)
Metallium (ASX: MTM) is scaling its Flash Joule Heating technology in Texas, supported by US government funding, recent capital raising and supply agreements aimed at advancing critical metals recovery and commercialisation.
.webp&w=828&q=75)
Codan (ASX: CDA) hit record highs following a strong FY26 and upbeat FY27 outlook. Driven by robust Communications and Minelab growth, the stock surged 23.9%. Despite technical overextension, market momentum remains high, fuelled by solid order intake and earnings visibility.

Transurban (ASX: TCL) has agreed to buy Canada Pension Plan Investment Board's Sydney toll road stakes for $4.5 billion in cash, lifting control of WestConnex, Westlink M7 and NorthConnex without raising equity.

Ampol (ASX: ALD) will buy Evie Networks for $225 million, creating Australia's largest public EV fast-charging network by bays. The debt-funded deal targets $30 million-plus earnings within three years, pending ACCC clearance.

Data#3 (ASX: DTL) expects first-half profit before tax to jump more than 40%, helped by one-off deals and extra interest income. Investors now weigh whether full-year earnings growth can hold up.
.webp&w=828&q=75)
GPT Group (ASX: GPT) reported a 21.6% increase in first-half 2026 net profit to A$400.1 million and announced an A$380 million Brisbane acquisition, supporting its diversified property strategy and development pipeline across Australia.

Viva Energy delivered a strong 1H26, with EBITDA and free cash flow surging on exceptional refining margins. However, earnings remain exposed to refinery cyclicality and operational risks, making normalised EPS of A$0.20–A$0.25 more appropriate for sustainable valuation.

Cochlear (ASX: COH) faces a shareholder class action over its FY26 profit forecast, just as its Nexa rollout, fully implantable trials and a November investor day shape the recovery story.
.webp&w=828&q=75)
Northern Star Resources (ASX: NST) has rejected Gold Fields’ A$38.7 billion takeover proposal amid increased pressure from Elliott Investment Management and leadership changes, while continuing to advance KCGM expansion, Hemi development, and its long-term growth strategy.

Veris (ASX: VRS) is shifting from commoditised surveying toward higher-margin digital, spatial and advisory services, with Digital & Spatial revenue now 28% of group sales. Margins remain thin, but strong free cash flow, net cash, and a growing pipeline support cautious optimism.

Reef Casino Trust (ASX: RCT) jumped roughly 29% to an all-time high after Iris Capital announced a $4.67 per unit offer for the remaining units. Thin trading and limited price history make the chart hard to read.
.webp&w=828&q=75)
Trading Halts and Suspensions can temporarily stop ASX share trading. Learn what they mean, why they happen, how they affect existing orders, and what investors should do when trading is interrupted.

Australia's central bank lifted the cash rate to 4.60%, its highest since 2011, with more tightening priced in. Here is how higher rates reshape valuations and which ASX sectors may hold up best.

Hormuz tensions are driving oil volatility, influencing Australia’s inflation and ASX performance. Woodside, Karoon Energy and Ampol offer exposure to higher energy prices or refining margins, but operational challenges, market turbulence and potential de-escalation remain key investment risks.

Australian shares weakened as persistent inflation, higher bond yields and softer domestic activity weighed on sentiment. Resource stocks showed relative strength, while the RBA’s September 29 rate decision and guidance remain key near-term market catalysts.

Global markets were volatile as higher US rates and Saudi pipeline disruption lifted oil costs, strengthened the dollar and pressured risk assets. Australia faces slowing growth, persistent inflation and a cautious ASX, with healthcare resilient while materials, technology and real estate weakened.

Global markets remained volatile as persistent inflation and geopolitical tensions reduced expectations of near-term Federal Reserve rate cuts. In Australia, high living costs, elevated fuel prices, weak consumer sentiment, and mortgage stress continue to constrain domestic demand, while the RBA maintains a cautious higher-for-longer policy stance.

The Risk-Reward Ratio (R/R) measures potential trade losses against expected profits using predefined stop-loss and take-profit levels. For long-term profitability, traders must combine a favourable R/R with a realistic win rate and strict capital management.
.webp&w=828&q=75)
Learn how the P/E ratio helps investors value ASX stocks, compare companies, identify potential opportunities, and understand why a low or high P/E does not always mean a stock is cheap or expensive.
.webp&w=828&q=75)
Learn how franking credits and fully franked dividends work for ASX investors, including tax offsets, dividend yields, the 45-day holding rule, and what to check before choosing Australian dividend stocks.
.webp&w=828&q=75)
Learn how to identify undervalued ASX stocks using seven key valuation metrics, including P/E, price-to-book, EV/EBITDA, PEG, free cash flow yield and dividend yield, while spotting potential value traps before making an investment decision.
Get access to Proactive Equities’ latest high conviction stock picks and trade signals
Our Standard Membership will give you access to
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights
Our Premium Membership will give you access to:
Short-term Trading Signals
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights
